-
Something wrong with this record ?
Hemangioma curative effect of PDL, alexandrite, Er:YAG and CO(2) lasers
E. Remlova, T. Dostalová, I. Michalusová, J. Vránová, L. Navrátil, J. Rosina,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NS9991
MZ0
CEP Register
PubMed
21793735
DOI
10.1089/pho.2011.3058
Knihovny.cz E-resources
- MeSH
- Analysis of Variance MeSH
- Adult MeSH
- Hemangioma radiotherapy MeSH
- Laser Therapy methods MeSH
- Lasers, Dye MeSH
- Lasers, Solid-State MeSH
- Lasers, Gas MeSH
- Middle Aged MeSH
- Humans MeSH
- Statistics, Nonparametric MeSH
- Retrospective Studies MeSH
- Aged MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
OBJECTIVE: Hemangioma is a mesenchymal benign tumor formed by blood vessels. Anomalies affect up to 10% of children and they are more common in females than in males. The aim of this study was to evaluate hemangioma treatment using four different types of lasers, namely, alexandrite, Er:YAG, CO(2), and pulsed dye laser (PDL). BACKGROUND DATA: The argon laser was the first to be used for dermatological patients, namely, with port wine stains (PWS) in the late 1960s and early 1970s. A variety of different lasers and light sources were useful in the treatment of vascular lesions, e.g., KTP, Nd:YAG, CO(2), PDL, and Er:YAG. METHODS: A group of 869 consecutive patients with hemangioma was retrospectively reviewed. The patients including in our study were divided into four groups according to the type of laser used: Alexandrite laser (n=85, 58 women and 20 men), CO(2) laser (n=78, 58 women and 20 men), Er:YAG laser (n=105, 87 women and 18 men), and PDL laser (n=601, 453 women and 148 men). All patients were treated in one session without anesthesia application. The ablative systems vaporized the tissues until the hemangioma was removed. The non-ablative systems used one shot, which destroyed the hemangioma blood vessels. RESULTS: For the treatment efficacy analysis, the following factors were evaluated: therapeutic effect (yes vs. no), loss of pigment (yes vs. no), and appearance of scar (yes vs. no). From results it was evident that the therapeutic effect of all the lasers except alexandrite was very high; almost 100%. In the CO(2) and the Er:YAG laser groups a high percentage of side effects was also observed. Exposure to these lasers caused loss of pigment and scar formation in many cases. The best therapeutic effect, with only minor side effects, has been achieved with the PDL laser. CONCLUSION: It was confirmed that PDL (595 nm, 1.5 ms, 7 mm, 9 - 11 J/cm(2)) had optimal effect without scars. Er:YAG or CO(2) laser radiation with specific characteristics was also useful for small superficial lesions.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12024403
- 003
- CZ-PrNML
- 005
- 20140917090927.0
- 007
- ta
- 008
- 120815e20110727xxu f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1089/pho.2011.3058 $2 doi
- 035 __
- $a (PubMed)21793735
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Remlová, Eva $u Ave Laser Centrum , Olomouc, Czech Republic. evareml@centrum.cz
- 245 10
- $a Hemangioma curative effect of PDL, alexandrite, Er:YAG and CO(2) lasers / $c E. Remlova, T. Dostalová, I. Michalusová, J. Vránová, L. Navrátil, J. Rosina,
- 520 9_
- $a OBJECTIVE: Hemangioma is a mesenchymal benign tumor formed by blood vessels. Anomalies affect up to 10% of children and they are more common in females than in males. The aim of this study was to evaluate hemangioma treatment using four different types of lasers, namely, alexandrite, Er:YAG, CO(2), and pulsed dye laser (PDL). BACKGROUND DATA: The argon laser was the first to be used for dermatological patients, namely, with port wine stains (PWS) in the late 1960s and early 1970s. A variety of different lasers and light sources were useful in the treatment of vascular lesions, e.g., KTP, Nd:YAG, CO(2), PDL, and Er:YAG. METHODS: A group of 869 consecutive patients with hemangioma was retrospectively reviewed. The patients including in our study were divided into four groups according to the type of laser used: Alexandrite laser (n=85, 58 women and 20 men), CO(2) laser (n=78, 58 women and 20 men), Er:YAG laser (n=105, 87 women and 18 men), and PDL laser (n=601, 453 women and 148 men). All patients were treated in one session without anesthesia application. The ablative systems vaporized the tissues until the hemangioma was removed. The non-ablative systems used one shot, which destroyed the hemangioma blood vessels. RESULTS: For the treatment efficacy analysis, the following factors were evaluated: therapeutic effect (yes vs. no), loss of pigment (yes vs. no), and appearance of scar (yes vs. no). From results it was evident that the therapeutic effect of all the lasers except alexandrite was very high; almost 100%. In the CO(2) and the Er:YAG laser groups a high percentage of side effects was also observed. Exposure to these lasers caused loss of pigment and scar formation in many cases. The best therapeutic effect, with only minor side effects, has been achieved with the PDL laser. CONCLUSION: It was confirmed that PDL (595 nm, 1.5 ms, 7 mm, 9 - 11 J/cm(2)) had optimal effect without scars. Er:YAG or CO(2) laser radiation with specific characteristics was also useful for small superficial lesions.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a analýza rozptylu $7 D000704
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a hemangiom $x radioterapie $7 D006391
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a laserová terapie $x metody $7 D053685
- 650 _2
- $a lasery barvivové $7 D054025
- 650 _2
- $a lasery plynové $7 D054020
- 650 _2
- $a lasery pevnolátkové $7 D053844
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a neparametrická statistika $7 D018709
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Dostálová, Taťjana, $d 1955- $7 mzk2004229214
- 700 1_
- $a Michalusová, Iva, $d 1986- $7 xx0169543
- 700 1_
- $a Vránová, Jana $7 xx0099427
- 700 1_
- $a Navrátil, Leoš, $d 1954- $7 nlk19990073595
- 700 1_
- $a Rosina, Jozef, $d 1956- $7 nlk19990073785
- 773 0_
- $w MED00181053 $t Photomedicine and laser surgery $x 1557-8550 $g Roč. 29, č. 12 (20110727), s. 815-825
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21793735 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120815 $b ABA008
- 991 __
- $a 20140917091338 $b ABA008
- 999 __
- $a ok $b bmc $g 946551 $s 781731
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 29 $c 12 $d 815-825 $e 20110727 $i 1557-8550 $m Photomedicine and laser surgery $n Photomed Laser Surg $x MED00181053
- GRA __
- $a NS9991 $p MZ0
- LZP __
- $a Pubmed-20120815/12/02